Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2011

01-07-2011 | Original Research

Temporal Trends in Presentation for Outpatient HIV Medical Care 2000–2010: Implications for Short-term Mortality

Authors: Paula S. Seal, MD, MPH, David A. Jackson, MD, Eric Chamot, PhD, James H. Willig, MD, Christa R. Nevin, MSPH, Jeroan J. Allison, MD, MSc, James L. Raper, DSN, CRNP, JD, Mirjam C. Kempf, PhD, MPH, Joseph E. Schumacher, PhD, Michael S. Saag, MD, Michael J. Mugavero, MD, MHSc

Published in: Journal of General Internal Medicine | Issue 7/2011

Login to get access

Abstract

Background

Many newly diagnosed patients present to outpatient care with advanced HIV infection. More timely HIV diagnosis and initiation of care has the potential to improve individual health outcomes and has public health implications.

Objective

To assess temporal trends in late presentation for outpatient HIV medial care as measured by CD4 count <200 cells/mm3 and the implications on short-term (1-year) mortality.

Design

We conducted a cohort study nested in a prospective HIV clinical cohort including patients establishing initial outpatient HIV treatment between 2000–2010. Time series regression analysis evaluated temporal trends in late presentation for care measured by the proportion of patients with a CD4 count <200 cells/mm3 or an opportunistic infection at enrollment, and also evaluated trends in short-term mortality.

Participants

Patients establishing initial outpatient HIV treatment between 2000–2010 at an academic HIV clinic.

Main Measures

The proportion of patients with a CD4 count <200 cells/mm3 or an opportunistic infection at initial presentation and short-term (1-year) mortality following clinic enrollment.

Key Results

Among 1121 patients, 41% had an initial CD4 count <200 cells/mm3, 25% had an opportunistic infection and 2.4% died within 1-year of their initial visit. Time series regression analysis demonstrated significant reductions in late presentation for HIV care and decreases in short-term mortality with temporal improvement preceding updated CDC HIV testing recommendations.

Conclusion

We observed a significant decline in the number of patients presenting for outpatient HIV care with advanced disease, particularly in 2006–2010. A significant trend in improved short-term survival among patients establishing HIV care was also observed, likely related to more timely presentation for outpatient care in more recent years.
Literature
1.
go back to reference Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV Prevalence Among Adults and Adolescents in the United States at the End of 2006. J Acquir Immune Defic Syndr. 2010;53(5):619–24.PubMed Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV Prevalence Among Adults and Adolescents in the United States at the End of 2006. J Acquir Immune Defic Syndr. 2010;53(5):619–24.PubMed
2.
go back to reference Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520–9.PubMedCrossRef Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520–9.PubMedCrossRef
3.
go back to reference Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2004. Atlanta: U.S. Department of Health and Human Services, Center for Disease Control and Prevention. 2005.16:1–46. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2004. Atlanta: U.S. Department of Health and Human Services, Center for Disease Control and Prevention. 2005.16:1–46.
4.
go back to reference Dybul M, Bolan R, Condoluci D, et al. Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J Infect Dis. 2002;185(12):1818–21.PubMedCrossRef Dybul M, Bolan R, Condoluci D, et al. Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J Infect Dis. 2002;185(12):1818–21.PubMedCrossRef
5.
go back to reference Gay CL, Napravnik S, Eron JJ Jr. Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors. AIDS. 2006;20(5):775–8.PubMedCrossRef Gay CL, Napravnik S, Eron JJ Jr. Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors. AIDS. 2006;20(5):775–8.PubMedCrossRef
6.
go back to reference Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral naive persons from 1990 to 2006. Clin Infect Dis. 2007;45(10):1369–74.PubMedCrossRef Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral naive persons from 1990 to 2006. Clin Infect Dis. 2007;45(10):1369–74.PubMedCrossRef
7.
go back to reference Mugavero JM, Castellano C, Edelman D, Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med. 2007;120(4):370–3.PubMedCrossRef Mugavero JM, Castellano C, Edelman D, Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med. 2007;120(4):370–3.PubMedCrossRef
8.
go back to reference Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9.PubMedCrossRef Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9.PubMedCrossRef
9.
go back to reference Fleishman JA, Yehia BR, Moore RD, et al. The Economic burden of late entry into medical care for patients with HIV infection. Med Care. 2010;48(12):1071–9.PubMedCrossRef Fleishman JA, Yehia BR, Moore RD, et al. The Economic burden of late entry into medical care for patients with HIV infection. Med Care. 2010;48(12):1071–9.PubMedCrossRef
10.
go back to reference Marks G, Crepaz N, Janssen R. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447–50.PubMedCrossRef Marks G, Crepaz N, Janssen R. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447–50.PubMedCrossRef
11.
go back to reference Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing in Adults, Adolescents, and Pregnant Women in Health-Care Settings. MMWR Morb Mortal Wkly Rep. 2006;55(RR14):1–17. Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing in Adults, Adolescents, and Pregnant Women in Health-Care Settings. MMWR Morb Mortal Wkly Rep. 2006;55(RR14):1–17.
12.
go back to reference Chen RY, Accortt NA, Westfall AO, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis. 2006;42(7):1003–10.PubMedCrossRef Chen RY, Accortt NA, Westfall AO, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis. 2006;42(7):1003–10.PubMedCrossRef
13.
go back to reference Mugavero MJ, Lin HY, Allison JJ, et al. Failure to establish HIV care: characterizing the“no show” phenomenon. Clin Infect Dis. 2007;45(1):127–30.PubMedCrossRef Mugavero MJ, Lin HY, Allison JJ, et al. Failure to establish HIV care: characterizing the“no show” phenomenon. Clin Infect Dis. 2007;45(1):127–30.PubMedCrossRef
14.
go back to reference Willig JH, Westfall AO, Allison J, et al. Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIVclinic in the electronic medical record era. Clin Infect Dis. 2007;45(5):658–61.PubMedCrossRef Willig JH, Westfall AO, Allison J, et al. Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIVclinic in the electronic medical record era. Clin Infect Dis. 2007;45(5):658–61.PubMedCrossRef
16.
go back to reference Harrell FE Jr. Regression modeling strategies with applications to linear models logistic regression, and survival analysis. New York, New York: Springer; 2001:16–26. Harrell FE Jr. Regression modeling strategies with applications to linear models logistic regression, and survival analysis. New York, New York: Springer; 2001:16–26.
17.
go back to reference Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6(4):356–65.PubMedCrossRef Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6(4):356–65.PubMedCrossRef
18.
go back to reference Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med. 2000;19(9):1141–64.PubMedCrossRef Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med. 2000;19(9):1141–64.PubMedCrossRef
19.
go back to reference Wylie R, Marler M, Lin H, et al. Project CONNECT: overcoming barriers to establishing HIV care. In: Program and abstracts of the 4th International Conference on HIV Treatment Adherence. Miami; 5–7 April 2009. Wylie R, Marler M, Lin H, et al. Project CONNECT: overcoming barriers to establishing HIV care. In: Program and abstracts of the 4th International Conference on HIV Treatment Adherence. Miami; 5–7 April 2009.
20.
go back to reference Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16:156–61.PubMed Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16:156–61.PubMed
21.
go back to reference Centers for Disease Control and Prevention. Expanded HIV Testing and Trends in Diagnoses of HIV Infection—District of Columbia, 2004–2008. MMWR Morb Mortal Wkly Rep. 2010;59(24):737–41. Centers for Disease Control and Prevention. Expanded HIV Testing and Trends in Diagnoses of HIV Infection—District of Columbia, 2004–2008. MMWR Morb Mortal Wkly Rep. 2010;59(24):737–41.
22.
go back to reference Sabin CA, Smith CJ, Youle M, et al. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS. 2006;20(1):67–71.PubMedCrossRef Sabin CA, Smith CJ, Youle M, et al. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS. 2006;20(1):67–71.PubMedCrossRef
23.
go back to reference Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS. 2006;20(18):2371–9.PubMedCrossRef Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS. 2006;20(18):2371–9.PubMedCrossRef
24.
go back to reference Lewden C, Rosenthal E, Burty C, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN 19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48(5):590–8.PubMedCrossRef Lewden C, Rosenthal E, Burty C, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN 19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48(5):590–8.PubMedCrossRef
25.
go back to reference Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.PubMedCrossRef Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.PubMedCrossRef
Metadata
Title
Temporal Trends in Presentation for Outpatient HIV Medical Care 2000–2010: Implications for Short-term Mortality
Authors
Paula S. Seal, MD, MPH
David A. Jackson, MD
Eric Chamot, PhD
James H. Willig, MD
Christa R. Nevin, MSPH
Jeroan J. Allison, MD, MSc
James L. Raper, DSN, CRNP, JD
Mirjam C. Kempf, PhD, MPH
Joseph E. Schumacher, PhD
Michael S. Saag, MD
Michael J. Mugavero, MD, MHSc
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2011
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1693-x

Other articles of this Issue 7/2011

Journal of General Internal Medicine 7/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine